Evidence map›Paper›PMID 29980383›Full record

ReviewThe Lancet. Infectious diseases2018

Laboratory medicine in Africa since 2008: then, now, and the future.

John N Nkengasong, Francois-Xavier Mbopi-Keou, Rosanna W Peeling, Katy Yao, Clement E Zeh, Miriam Schneidman, Renuka Gadde, Alash'le Abimiku, Philip Onyebujoh, Deborah Birx and 1 more

Abstract readHistorical ArticleReview
In one paragraph

Review in The Lancet. Infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A qualitative study of factors resulting in care delays for adults with meningitis in Zambia.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

John N NkengasongDivision of Global HIV/TB, Centres for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: jcn5@cdc.gov.
Francois-Xavier Mbopi-KeouFaculty of Medicine and Biomedical Sciences, University of Yaounde 1, Yaounde, Cameroon.
Rosanna W PeelingLondon School of Hygiene and Tropical Medicine, London, UK.
Katy YaoDivision of Global HIV/TB, Centres for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Clement E ZehDivision of Global HIV/TB, Centres for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Miriam SchneidmanLondon School of Hygiene and Tropical Medicine, London, UK; World Bank, Washington, DC, USA.
Renuka GaddeBecton, Dickinson and Company, Franklin Lakes, NJ, USA.
Alash'le AbimikuUniversity of Maryland, Institute of Human Virology, Baltimore, MD, USA.
Philip OnyebujohWorld Health Organization Regional Office for Africa, Brazzaville, Congo.
Deborah BirxOffice of the Global AIDS Coordinator, Washington, DC, USA.
Shannon HaderDivision of Global HIV/TB, Centres for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA.

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

The Maputo Declaration of 2008 advocated for commitment from global stakeholders and national governments to prioritise support and harmonisation of laboratory systems through development of comprehensive national laboratory strategies and policies in sub-Saharan Africa. As a result, HIV laboratory medicine in Africa has undergone a transformation, and substantial improvements have been made in diagnostic services, networks, and institutions, including the development of a competent workforce, introduction of point-of-care diagnostics, and innovative quality improvement programmes that saw more than 1100 laboratories enrolled and 44 accredited to international standards. These improved HIV laboratories can now be used to combat emerging continental and global health threats in the decades to come. For instance, the unprecedented Ebola virus disease outbreak in west Africa exposed the severe weaknesses in the overall national health systems in affected countries. It is now possible to build robust health-care systems in Africa and to combat emerging continental and global health threats in the future. In this Personal View, we aim to describe the remarkable transformation that has occurred in laboratory medicine to combat HIV/AIDS and improve global health in sub-Saharan Africa since 2008.

Indexed as

Africa South of the SaharaClinical Laboratory TechniquesCommunicable Diseases, EmergingDiagnostic ServicesHealth PolicyHistory, 20th CenturyHistory, 21st CenturyHIV InfectionsHumans

Identifiers

PMID29980383
PMCPMC13081755

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.